-
Tumor-Educated Platelets lncRNA-STARD4-AS1 and ELOA-AS1 as Potential Novel Biomarkers for the Early Diagnosis of Non-Small Cell Lung Cancer
03 Jan 2025 11:13 GMT
… -small cell lung cancer (NSCLC), mainly divided into adenocarcinoma (LUAD) and … than 80% of all lung cancers,1 has the highest … TEPs enabled blood-based lung cancer diagnosis and progression … diagnosis and subtyping of lung cancer. Lung Cancer. 2023;178:28–36 …
-
A Rare Case with Recurrent Abdominal Pain as the First Symptom: AL Amyloidosis with Colon Involvement Combined with Pulmonary Adenocarcinoma
03 Jan 2025 18:02 GMT
… anemia, amyloidosis, and lung cancer might be coincidental, some … with lung cancer compared to AL amyloidosis. Lung cancer might … all adenocarcinoma, while the pathology type of lung cancer combined … al. Amyloidosis and lung cancer. Clin Lung Cancer. 2003;4(4): …
-
FDA Approval Insights: Zenocutuzumab for NRG1+ Pancreatic Adenocarcinoma and NSCLC: With Alison Schram, MD
02 Jan 2025 23:40 GMT
… treated advanced pancreatic adenocarcinoma or non–small cell lung cancer (NSCLC) harboring … , unresectable, or metastatic pancreatic adenocarcinoma harboring an NRG1 gene fusion … ), in which patients with pancreatic adenocarcinoma (n = 30) achieved an …
-
FDA’s December 2024 Oncology Approvals and Designations
03 Jan 2025 21:04 GMT
… -positive non–small cell lung cancer (NSCLC) and pancreatic … nonsquamous non–small cell lung cancer (NSCLC) harboring EGFR mutations … NRG1-positive pancreatic ductal adenocarcinoma.
FDA Accepts sBLA … extensive-stage small cell lung cancer in adult patients …
-
FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions
03 Jan 2025 01:13 GMT
… non-small cell lung cancer and pancreatic adenocarcinoma. It’s the … limited-stage small cell lung cancer that has not progressed … limited-stage small cell lung cancer.
—Xcovery Holdings drug ensartinib … for non-small cell lung cancer. The injectable version is …
-
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
02 Jan 2025 19:53 GMT
… (RCC), melanoma, non–small cell lung cancer (NSCLC), head and neck squamous … , gastroesophageal junction cancer, and esophageal adenocarcinoma.1 However, nivolumab and hyaluronidase …
-
Cancer Therapies Approved by the FDA in December 2024
02 Jan 2025 17:07 GMT
… -small cell lung cancer (NSCLC) or pancreatic adenocarcinoma whose tumors … NRG1 fusion-positive pancreatic adenocarcinoma whose disease had … Limited-Stage Small Cell Lung Cancer
Imfinzi (durvalumab) was … limited-stage small cell lung cancer who have not …
-
FDA Approves Nivolumab and Hyaluronidase-nvhy for Subcutaneous Use in Patients With Solid Tumors
02 Jan 2025 15:47 GMT
… carcinoma, melanoma, non-small cell lung cancer, head and neck squamous cell … , gastroesophageal junction cancer, and esophageal adenocarcinoma.1,2
Nivolumab and hyaluronidase …
-
December 2024 — CDMO Opportunities And Threats Report
02 Jan 2025 09:38 GMT
… 3A ALK-positive nonsmall-cell lung cancer (NSCLC) after complete tumour … 3A ALK-positive nonsmall-cell lung cancer (NSCLC) after complete … 3A ALK-positive nonsmall-cell lung cancer (NSCLC) after complete … (G/GEJ) adenocarcinoma whose tumours express PD-L1 …
-
Tevimbra by BeiGene for Gallbladder Cancer: Likelihood of Approval
01 Jan 2025 06:36 GMT
… non-small cell lung cancer, esophageal squamous cell … non-small cell lung cancer, sarcomas, cholangiocarcinoma, … lung cancer, metastatic adenocarcinoma of the pancreas, non-small cell lung cancer … sarcomas, small-cell lung cancer, squamous cell carcinoma …
About
© 1995-2025